Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Amphotec now approved in 20 countries

Feb. 28, 1997

Pfizer's new antifungal agents

Feb. 27, 1997

Favorable results reported for Mentax

Feb. 26, 1997

Recurrent herpes treatment development advances

Feb. 26, 1997

Zanamivir enters pivotal trials

Feb. 26, 1997

Antiherpesvirus agents reported by Bio-Mega/Boehringer Ingelheim

Feb. 25, 1997

Antiviral nucleoside analogues available for licensing

Feb. 24, 1997

Alpha-Beta/MycoTox antifungal collaboration

Feb. 21, 1997

New agreement reached for Searle's Maxaquin

Feb. 20, 1997

Antifungals from Schering-Plough

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...